Cite

HARVARD Citation

    Santagostino, E. et al. (2018). A contemporary look at FVIII inhibitor development: still a great influence on the evolution of hemophilia therapies. Expert review of hematology. 11 (2), pp. 87-97. [Online]. 
  
Back to record